Kevin J Appelbaum Better Therapeutics, Inc. (BTTX) insider trading activity

BTTX Quotes by TradingView

Kevin J Appelbaum is Chief Executive Officer of Better Therapeutics, Inc.. Currently has a direct ownership of 6,250 shares of BTTX, which is worth approximately $0. The most recent transaction as insider was on Mar 31, 2022, when has been sold 2,500 shares (Common Stock) at a price of $1.97 per share, resulting in proceeds of $4,925. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.25K
0% 3M change
0% 12M change
Total Value Held $0

Kevin J Appelbaum Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2022
BUY
Open market or private purchase
$4,925 $1.97 p/Share
2,500 Added 28.57%
6,250 Common Stock
Dec 20 2021
BUY
Open market or private purchase
$4,600 $4.6 p/Share
1,000 Added 21.05%
3,750 Common Stock
Dec 15 2021
BUY
Open market or private purchase
$3,533 $4.71 p/Share
750 Added 21.43%
2,750 Common Stock
Dec 10 2021
BUY
Open market or private purchase
$5,980 $5.98 p/Share
1,000 Added 33.33%
2,000 Common Stock
Dec 03 2021
BUY
Open market or private purchase
$3,215 $6.43 p/Share
500 Added 33.33%
1,000 Common Stock
Dec 02 2021
BUY
Open market or private purchase
$3,420 $6.84 p/Share
500 Added 50.0%
500 Common Stock
KJA

Kevin J Appelbaum

Chief Executive Officer
San Francisco, CA

Track Institutional and Insider Activities on BTTX

Follow Better Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTTX shares.

Notify only if

Insider Trading

Get notified when an Better Therapeutics, Inc. insider buys or sells BTTX shares.

Notify only if

News

Receive news related to Better Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BTTX